Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
about
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adultsIgG4 Characteristics and Functions in Cancer ImmunityAgeing Is Associated with Decreases in Appetite and Energy Intake--A Meta-Analysis in Healthy AdultsClinical trials of transplant tolerance: slow but steady progress.T cell targeted immunotherapy for autoimmune disease.The poor contribution of chimpanzee experiments to biomedical progress.Targeting CLEC9A delivers antigen to human CD141(+) DC for CD4(+) and CD8(+)T cell recognitionMonoclonal antibody-induced cytokine-release syndrome.Glycation, Oxidation and Glycoxidation of IgG: A Biophysical, Biochemical, Immunological and Hematological study.Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions.Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility.Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.
P2860
Q24645675-D2B81920-5692-4968-9800-39636304FB79Q26770244-C43ADBF7-A6AD-4F56-B742-6C63AF7F8BF3Q28074100-784976F3-29D2-4B22-9CBD-481C63E61A50Q35157558-310CF05E-1E96-491D-8DBA-4995FCA3D9B7Q36359571-5D32C420-6206-4343-8ECD-144AE79C4749Q36985853-86A4279A-11A4-44BD-9EF6-C8A8D59B3CBCQ37277188-EC53915F-FF20-4698-8C1F-0A445EA88AB5Q37755276-2A7C377D-AA93-4874-8F2D-EE7B32EA772EQ38631878-BC837A8F-1AC1-4CBC-8514-E63362AE246EQ38748910-291CA741-1FE6-4169-9272-1ECA62888E0BQ39830543-E3C8658B-44B6-440D-89DD-130C5AD9A1C2Q41868216-BB78737B-1201-4F6D-B9F4-95CB4A46579CQ47952891-9692664B-920A-42E5-8213-7696A38383F4
P2860
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@ast
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@en
type
label
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@ast
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@en
prefLabel
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@ast
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@en
P2093
P356
P1433
P1476
Modification of the Fc region ...... CD4(+) T cells in chimpanzees.
@en
P2093
Anderson DR
Braslawsky G
Brigham-Burke M
Bugelski PJ
Dal Monte P
Hariharan K
P304
P356
10.1006/CLIM.2000.4975
P577
2001-02-01T00:00:00Z